The obvious ability of defined lectins to activate (non)specific defen
se mechanisms supports the assumption that lectin-carbohydrate interac
tions may induce clinically beneficial immunomodulation. Recent invest
igations proved that lectins, especially small nontoxic doses of galac
toside-specific mistletoe lectin (ML-1), have immuno-emodulatory poten
cy.